hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 07:38:49 - browse：8573

Cambridge: AbbVie — Ruby Wallau for STAT

AbbVie will pay $10 billion for the biotech firm Immunogen, the company said Thursday, acquiring an approved treatment for ovarian cancer and buying into a burgeoning area of oncology.

Under the agreement, AbbVie will pay $31.26 per share in cash for Immunogen, a nearly 100% premium to the company’s recent trading price. Central to the deal, expected to close in the middle of next year, is Elahere, an Immunogen product that won Food and Drug Administration approval for advanced ovarian cancer in 2022.

Elahere is among a surging class of cancer medicines called antibody-drug conjugates, or ADCs, which are designed to deliver a targeted dose of chemotherapy directly to tumor cells while sparing healthy tissues. AbbVie’s acquisition is the latest multibillion-dollar deal in the space, following Merck’s $22 billion agreement with ADC specialist Daiichi Sankyo and Pfizer’s $43 billion buyout of Seagen earlier this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

knowledge

WSS

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Senate panel passes drug pricing bills, but drops one PBM reform

Global childhood vaccinations edge closer to pre

Senate panel passes drug pricing bills, but drops one PBM reform

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Biogen nominates mother of director’s child to replace him on board

Wikipedia

hotspot

Wikipedia

Hollywood unions extend contract negotiations for actors

J&J expands global access to TB drug amid advocacy campaign

Bright Health sells Medicare Advantage business to Molina

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Novavax promises a turnaround & Lilly roils the obesity market

Biden administration plans revamp of organ transplant system

Dobbs anniversary: the lost opportunity of abortion as health care

Woman gored by Bison at Yellowstone

Tori Bowie and the unacceptable rates of Black maternal death

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

entertainment

J&J expands global access to TB drug amid advocacy campaign

Congress likely to miss an opportunity to fix drug shortages issue

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Altering the blood type of lungs raises potential for universal organs for transplants

Federal judge rules Oregon’s tough new gun law is constitutional

J&J expands global access to TB drug amid advocacy campaign

focus

knowledge

entertainment

knowledge